Impact of metformin on survival outcome of esophageal squamous cell carcinomas patients undergoing surgical resection: a multicenter retrospective study
Journal of thoracic disease, pp. 830-838, 2020.
Esophageal squamous cell carcinomas (ESCC)disease-free survival (DFS)metforminoverall survival (OS)type 2 diabetes mellitus (T2DM)
T2DM was again associated with poorer survival in ESCC patients, and metformin may improve the prognosis of these patients.
Full Text (Upload PDF)
PPT (Upload PPT)